ADMA Biologics
ADMA
ADMA
91 hedge funds and large institutions have $140M invested in ADMA Biologics in 2020 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 41 increasing their positions, 14 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
8% more capital invested
Capital invested by funds: $130M → $140M (+$9.86M)
1.39% more ownership
Funds ownership: 54.73% → 56.11% (+1.4%)
Holders
91
Holding in Top 10
1
Calls
$1.99M
Puts
$1.41M
Top Buyers
| 1 | +$14.6M | |
| 2 | +$3.83M | |
| 3 | +$3.74M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$3.74M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.59M |
Top Sellers
| 1 | -$5.14M | |
| 2 | -$2.4M | |
| 3 | -$1.49M | |
| 4 |
Jane Street
New York
|
-$370K |
| 5 |
Millennium Management
New York
|
-$207K |